| Product NDC: | 24856-001 |
| Proprietary Name: | JETREA |
| Non Proprietary Name: | ocriplasmin |
| Active Ingredient(s): | .5 mg/.2mL & nbsp; ocriplasmin |
| Administration Route(s): | INTRAVITREAL |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 24856-001 |
| Labeler Name: | ThromboGenics Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125422 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20121031 |
| Package NDC: | 24856-001-00 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (24856-001-00) > .2 mL in 1 VIAL, SINGLE-USE |
| NDC Code | 24856-001-00 |
| Proprietary Name | JETREA |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (24856-001-00) > .2 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 24856-001 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ocriplasmin |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVITREAL |
| Start Marketing Date | 20121031 |
| Marketing Category Name | BLA |
| Labeler Name | ThromboGenics Inc. |
| Substance Name | OCRIPLASMIN |
| Strength Number | .5 |
| Strength Unit | mg/.2mL |
| Pharmaceutical Classes |